Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.
about
Aortic stenosis: An updateRosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosisCellular mechanisms of aortic valve calcificationIncreased dietary intake of vitamin A promotes aortic valve calcification in vivoLarge animal models of cardiovascular diseaseIn vitro models of aortic valve calcification: solidifying a systemMolecular and cellular aspects of calcific aortic valve diseaseRegulation of valve endothelial cell vasculogenic network architectures with ROCK and Rac inhibitors.Novel biological markers of bone: from bone metabolism to bone physiologyVascular calcification: pathobiology of a multifaceted diseaseVitamin D and osteogenic differentiation in the artery wallCholesterol in vascular and valvular calcificationSox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve developmentTransforming growth factor Beta2 is required for valve remodeling during heart developmentReduced sox9 function promotes heart valve calcification phenotypes in vivoWnt signaling in heart valve development and osteogenic gene inductionPathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosisCalcific aortic valve stenosis: methods, models, and mechanismsMechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.Inflammation and the osteogenic regulation of vascular calcification: a review and perspective.The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents.Sox9 transcriptionally represses Spp1 to prevent matrix mineralization in maturing heart valves and chondrocytesDistinct mitral valve proteomic profiles in rheumatic heart disease and myxomatous degeneration.Transcriptional regulation of heart valve development and disease.An autonomous BMP2 regulatory element in mesenchymal cells.Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.One problem two issues! Left ventricular systolic and diastolic dysfunction in aortic stenosisDifferential Aortic and Mitral Valve Interstitial Cell Mineralization and the Induction of Mineralization by Lysophosphatidylcholine In Vitro.Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cellsDifferential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valvesCardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease.Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation.Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation.Attenuation of chondrogenic transformation in vascular smooth muscle by dietary quercetin in the MGP-deficient mouse modelGene expression variation between African Americans and whites is associated with coronary artery calcification: the multiethnic study of atherosclerosisWnt16 attenuates TGFβ-induced chondrogenic transformation in vascular smooth muscle.The long non-coding HOTAIR is modulated by cyclic stretch and WNT/β-CATENIN in human aortic valve cells and is a novel repressor of calcification genesRole for circulating osteogenic precursor cells in aortic valvular disease.
P2860
Q24569646-87155E4F-E7B1-4D07-A73E-46BF32BC91BFQ24595023-76418E3F-B4E2-4FE0-86F4-DA02351005CFQ24613042-F0652B24-19B8-44C7-8E3B-A2668BE7598DQ24630155-6C1BBA0F-7170-4047-82EE-F4F2C42815E7Q26766350-B3C4D893-24CF-4C87-91A3-63361336786BQ27022156-02C8B6BA-2E35-4E4F-BAD0-0A6BDED288C5Q27026105-E59C0418-AE4F-47A1-99BC-DEFB3B18CA47Q27308671-59A17C96-D1F1-4F50-B451-6CCA5E66EC44Q28067712-35FC7907-3D8F-4C16-9E22-76B797AFB0BBQ28282418-82B0E0F5-570A-4F2A-99DA-93E43EE1DE91Q28284363-4178276E-7392-48E5-AF4E-15779A1DE3A1Q28361780-1ECD9211-DD08-42D2-A623-6C90B8F3B300Q28504526-C8D7075C-7383-440C-8D5E-7728FE5417D9Q28505676-4C61EE53-D5A2-4B91-A6EB-95464D6B6535Q28506607-065A7B0E-A841-4881-871A-6B5AD9A896D0Q28586329-35724514-67CB-4B97-9FDA-858D2045743CQ30234828-4CD25C3C-6BAB-4558-A7B1-0B7CB9B0D04FQ30502726-91343FD3-E535-4A27-BF13-20ECAFB1571FQ30503246-949D2273-485C-48B2-8059-2900585E2E82Q33589249-8CE3B0A1-6C5C-459B-8905-AFA996EF15FFQ33782750-E8264DE3-96C1-416B-BF99-3814F98E53F5Q33819169-EC189B55-93AE-4CE2-A0A5-412E91D2E8ABQ33968020-53D61944-ABC7-46AA-9990-91D22C25E788Q34064669-40EF2D73-C005-4BE8-8E59-FE426691160BQ34156310-A883FAAA-0985-4B19-BE70-627B744E519FQ34307567-4D1D164A-512A-444B-87A2-6812620E156FQ34343759-D89C1721-96DB-4995-A58F-00A87FDC82FDQ34353340-0AE8A563-455C-4175-9362-20BA5F31D2A3Q34357901-3BB63ED9-B186-4C08-82BE-8A7F15239DE1Q34534890-366A4F0A-CD3A-4FD9-AC5C-31DF942F21ECQ34550461-C43B1C28-4CF0-4BC5-AEE4-8DCCA2AD6182Q34560992-9EEAE636-EA32-45EB-AA9E-B1D77EF5D427Q34598006-FB16F484-BBED-4035-97BB-D23C16421640Q34600308-0772C67C-6BAE-4BAE-8E7B-55025B291D13Q34900192-4A81B08C-EDBE-4E2F-8EDD-50601794F401Q35010277-9CAC90BB-EE3F-4828-93E3-A478864CF2EBQ35095203-C04ADA2D-70F4-4895-8E1D-5E76D0217EDFQ35130798-AF978246-03B8-487E-8426-BC1D91C5EEFEQ35161520-550CED73-F20B-4C13-A056-18D11B983EE1Q35563353-F944A598-F5A8-42D6-9281-D8AC29E716B3
P2860
Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human degenerative valve disea ...... eptor-mediated bone formation.
@en
Human degenerative valve disea ...... eptor-mediated bone formation.
@nl
type
label
Human degenerative valve disea ...... eptor-mediated bone formation.
@en
Human degenerative valve disea ...... eptor-mediated bone formation.
@nl
prefLabel
Human degenerative valve disea ...... eptor-mediated bone formation.
@en
Human degenerative valve disea ...... eptor-mediated bone formation.
@nl
P2093
P2860
P1476
Human degenerative valve disea ...... eptor-mediated bone formation.
@en
P2093
Edwin C McGee
Frank C Caira
Nalini M Rajamannan
Patrick M McCarthy
Robert O Bonow
Shahbudin H Rahimtoola
Stuart R Stock
Thomas C Spelsberg
Thomas G Gleason
P2860
P304
P356
10.1016/J.JACC.2006.02.040
P407
P577
2006-03-20T00:00:00Z